Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer

by Seongho Park, Yoo‐Duk Choi, Jieun Kim, Bo‐Gun Kho, Cheol‐Kyu Park, In‐Jae Oh, Young‐Chul Kim
Published 2020-02-01

Myasthenia gravis and myopathy after nivolumab treatment for non‐small cell lung carcinoma: A case report

by Je‐Seong Kim, Tai‐Seung Nam, Jieun Kim, Bo‐Gun Kho, Cheol‐Kyu Park, In‐Jae Oh, Young‐Chul Kim
Published 2019-10-01

Efficacy and dose of afatinib in patients with non‐small cell lung cancer after failure of prior gefitinib or erlotinib treatment

by Hayoung Choi, Jae‐Kyeong Lee, Hyung‐Joo Oh, Min‐Seok Kim, Bo Gun Kho, Cheol Kyu Park, In‐Jae Oh, Young‐Chul Kim
Published 2021-05-01

Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery

by Bo Gun Kho, Ha-Young Park, Hyun-Joo Cho, Cheol Kyu Park, Young-Chul Kim, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Yoo-Duk Choi, Seung-Won Lee, In-Jae Oh
Published 2020-11-01

Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report

by Hong-Joon Shin, Min-Seok Kim, Bo Gun Kho, Ha Young Park, Tae-Ok Kim, Cheol-Kyu Park, In-Jae Oh, Yu-Il Kim, Young-Chul Kim, Yoo-Duk Choi, Sung-Chul Lim
Published 2020-03-01

Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness.

by Tae-Ok Kim, Jae-Kyeong Lee, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Min-Seok Kim, Bo Gun Kho, Cheol-Kyu Park, In-Jae Oh, Young-Chul Kim, Ha Young Park, Hong-Joon Shin
Published 2021-01-01

Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression

by Ha-Young Park, M.D., In-Jae Oh, M.D., Ph.D., Bo Gun Kho, M.D., Tae-Ok Kim, M.D., Hong-Joon Shin, M.D., Cheol Kyu Park, M.D., Ph.D., Yong-Soo Kwon, M.D., Ph.D., Yu-Il Kim, M.D., Ph.D., Sung-Chul Lim, M.D., Ph.D., Young-Chul Kim, M.D., Ph.D., Yoo-Duk Choi, M.D., Ph.D.
Published 2019-07-01